Expand VIR Menu
VIR MENU

VIR Latest Press Releases

-- February 9, 2026 --

Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results Business Wire 4:05 PM

-- January 12, 2026 --

Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones Business Wire 8:00 AM

-- January 5, 2026 --

Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire 4:05 PM

-- December 16, 2025 --

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program Business Wire 4:05 PM

-- November 19, 2025 --

Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference Business Wire 4:05 PM

-- November 9, 2025 --

Vir Biotechnology Announces AASLD The Liver Meeting Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile Business Wire 6:07 PM

-- November 7, 2025 --

Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference Business Wire 9:00 AM

-- November 5, 2025 --

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results Business Wire 4:05 PM

-- November 3, 2025 --

Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta Business Wire 8:00 AM

-- October 22, 2025 --

Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025 Business Wire 4:05 PM

-- October 9, 2025 --

Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer Business Wire 4:05 PM

-- October 7, 2025 --

Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD's The Liver Meeting 2025 Business Wire 8:00 AM
Market Data Delayed 15 Minutes